Background {#Sec1}
==========

Worldwide, many countries routinely collect data on HIV care and services, which is then used to provide national and international indicators about the HIV epidemic. These indicators provide information and insight to aid policymakers and planners when making important decisions about HIV services, to request for further research, and in advocacy for new initiatives and funding \[[@CR1], [@CR2]\].

Sub-Saharan Africa is home to approximately 71% of the people living with HIV \[[@CR3]\]. Zambia is a high HIV burden country within sub-Saharan Africa, having a national HIV prevalence of 11.6% and almost 980,000 people living with HIV in 2016 \[[@CR4]--[@CR6]\]. The HIV epidemic in Zambia is generalised and is mainly attributed to unprotected heterosexual activity \[[@CR7]\]. This creates a need to monitor the HIV epidemic by focusing on indicators of effective prevention and on the quality of the HIV services in Zambia \[[@CR8]\]. Six key service areas are prioritised in the country for prevention and treatment of HIV. These are (1) voluntary medical male circumcision (VMMC); (2) condom programming; (3) behavioural change; (4) HIV testing and counselling (HTC); (5) prevention of mother-to-child transmission (PMTCT); and (6) treatment and retention in care \[[@CR7]\]. At national level, these programmes are monitored using routinely collected data and periodic country representative surveys.

Routinely collected data can also be used to understand the effectiveness of services and to improve decision-making in the healthcare system. The benefits in using routinely collected data include wider coverage of recorded items from across the whole country and the longitudinal nature of the data allowing estimation of trends and changes in the use of services \[[@CR9]\]. The use of these data in this way is cost effective, as it is already collected and readily available for analysis. Therefore, research can be conducted in a timely and cost-efficient manner \[[@CR10]\]. It can be the basis of sampling for clinical trials, cohort studies and case-control studies, as matched case-control analyses can be performed repeatedly over long time periods \[[@CR11]\]. Routinely collected data are usually clinic based, but results from analysis of such data can be generalisable to the whole population if the services are widely used and serve all sections of society \[[@CR10]\]. One of the main data collection systems for the routine collection of data from the HIV programme is SmartCare, which is one of the largest electronic patient monitoring systems (PMS) in Africa and is used in South Africa and Ethiopia \[[@CR12]\]. In Zambia, the SmartCare database is used as a PMS for HIV services, and the data are used to monitor and plan improvements in the country's HIV programme. SmartCare has been used as a pilot since 2004, and was officially rolled out in 2006 \[[@CR13]\], with 528 clinics using SmartCare in 2012, and implemented in more than 700 clinics that provide antiretroviral therapy services by 2013 \[[@CR14], [@CR15]\]. SmartCare data, in facilities where it is available, is used to provide aggregate reports for DHIS2, and other health management information systems at the district level. In some health facilities, the SmartCare data can inform the drug ordering and the laboratory information systems, but this is not possible in most health facilities in Zambia.

Research has revealed that countries like Zambia, with one of the highest HIV/AIDS prevalence rates in Africa, are not the largest contributors to research on HIV/AIDS. This was evident in a review of three journals focusing on HIV/AIDS \[[@CR16]\], which showed that the United States of America and Western Europe accounted for 85% of all published articles between 1986 and 2003. In sub-Saharan Africa, 50% of all publications on Africa indexed in PubMed between 1981 and 2009 were from South Africa, Uganda and Kenya. Zambia was ranked seventh, with 922 publications within that period, translating to approximately 32 publications per year \[[@CR17]\]. This paper is a review of published studies using routinely collected HIV data from Zambia from 2004 to 2015, within the six areas of focus (VMMC, condom programming, behavioural change, HTC, PMTCT, and treatment and retention in care). We sought to examine the extent to which routinely collected HIV data has been analysed quantitatively for publication and identify gaps that exist across the six prioritised areas. It is hoped that findings from this review will potentially inform guidelines and strategies as well as stimulate policy dialogue in the use of routinely collected data.

Methods {#Sec2}
=======

Literature search strategy {#Sec3}
--------------------------

We conducted a literature review of studies that reported results from routinely collected HIV data in Zambia. We utilised a detailed search protocol and standard systematic review procedures (Additional file 1) for papers which utilised routinely collected HIV data from primary to tertiary healthcare settings, using SmartCare or other electronic or paper-based PMS data in Zambia. We included studies published between 2004 (when SmartCare started) and November 2015. The search was conducted between July and November 2015. We selected only original articles from peer-reviewed journals on HIV studies conducted in Zambia utilising routinely collected data and quantitative methods of data analysis. All reported studies relevant to our search topic were reviewed, regardless of sample size. Articles were excluded if they were not written in English or where the specific results for Zambia were not reported from regional or multi-country studies. Clinical trials and intervention studies that did not take place under routine care conditions were also excluded, although community trials that referred patients to the routine clinics were included.

We searched the PubMed, Google Scholar, Directory of Open Access Journals, and African Journals Online databases for articles on HIV in Zambia that utilised routinely collected data (Table [1](#Tab1){ref-type="table"}). We used a combination of search words that included "HIV", "SmartCare" and "routinely collected data", among others (Table [1](#Tab1){ref-type="table"}). One of the authors (TM) searched for articles and extracted the data from included studies, while another author (SG) reviewed the extracted data for discrepancies. All discrepancies were discussed and resolved. A standard data extraction form was used to review and extract data such as sample size, study design, number of study sites, dates of data collection, year of publication and main outcomes.Table 1Search strategyDatabaseSearch termsGoogle Scholar (July 3, 2015)HIV + SmartCare + Zambia HIV + routine + data HIV/AIDS + "routinely collected data" + Zambia Condom + HIV + ZambiaPubMed (July 15, 2015)HIV/AIDS + "routinely collected data" + Zambia + routine data Condom + HIVAfrican Journals Online (November 6, 2015)HIV + routine + data + Zambia + condom + \"routinely collected data\"﻿ + SmartCareDirectory of Open Access Journals (November 11, 2015)HIV + Zambia + condom + \"routinely collected data﻿\" + SmartCare

Data analysis {#Sec4}
-------------

The selected papers could only be categorised by the six programme areas as the range of topics covered prevented aggregated statistical analysis of findings. All eligible articles were further grouped by the populations used in the papers, namely adult (males and females above 15 years of age), women and children (under the age of 15 years) to assess how effectively the priority areas cover the different age categories. The eligible articles were also analysed based on institutions that collaborated to publish the articles.

Results {#Sec5}
=======

A total of 1846 titles were reviewed and 1048 were excluded because they were not published in journals (n = 482), were published before 2004 (n = 335), or the topics were not relevant (n = 231). A total of 791 abstracts were then reviewed. Of these, some were excluded because they were clinical trials (n = 39), qualitative studies (n = 110), or did not use routinely collected data (n = 470), or were multi-country studies that did not include specific data on Zambia (n = 103) (Fig. [1](#Fig1){ref-type="fig"}). From these, 69 full length articles were selected, of which seven were found to be multi-country studies that did not use routinely collected data, and the remaining 62 were considered for categorisation. The articles were then classified into the six HIV service areas.Fig. 1Flow diagram of review of routinely collected HIV data in Zambia

Overall, 15 articles addressed PMTCT, four focussed on HTC, four covered social and behavioural change (Table [2](#Tab2){ref-type="table"}), and 39 covered treatment and retention in care. Our search did not reveal any articles that used routinely collected HIV data in Zambia reporting outcomes in the areas of condom programming or VMMC utilising quantitative methods.Table 2Studies utilising routinely collected data in HIV testing and counselling, prevention of mother-to-child transmission (PMTCT) and social behavioural change programmes in ZambiaFirst author, year of publicationData collection periodSample sizeSampled populationOutcomes assessedHIV testing and counselling Topp et al. \[[@CR31]\]2008--20112239Adults onlyCD4 count, haemoglobin level, BMI, education level, partner's HIV status Topp et al. \[[@CR32]\]2008--201044,420Adults onlyHIV testing, enrolment into care Czaicki et al. \[[@CR33]\]2011--201210,806Adult couplesCohabitation length, prior HIV testing, current antiretroviral use Kankasa et al. \[[@CR34]\]2006--200715,670ChildrenHIV testing, testing coverage, HIV counselling,PMTCT Killam et al. \[[@CR35]\]2007--200813,917Women initiating ARTWomen eligible for ART, women initiating ART Stringer et al. \[[@CR36]\]200117,263Women onlyWomen tested, mothers and babies receiving NVP Stringer et al. \[[@CR37]\]20038787Mother baby pairsGravidity, offered testing, tested, infant given NVP Chibwesha et al. \[[@CR38]\]2007--20101813Mother baby pairsCD4 count, date of highly active ART initiation, infant HIV status Liu et al. \[[@CR39]\]2007-- 200913,888Women initiating ARTCD4 count, haemoglobin level, syphilis, tuberculosis, HIV status Chintu et al. \[[@CR40]\]2004--20066740Women on ARTMortality, NVP exposure, CD4 count, haemoglobin level Mandala et al. \[[@CR41]\]2007--200814,815Women on ARTCD4 count, initiated on ART Torpey et al. \[[@CR20]\]2005--20089723Women on ARTHIV testing, enrolled to care, received ART Chibwesha et al. \[[@CR42]\]2009--201018,407Women initiating ARTCD4 count, haemoglobin level, use of contraceptives Stringer et al. \[[@CR43]\]2002--2006243,302Women and baby pairsHIV status, number testing positive, attended antenatal care Mulindwa \[[@CR44]\]Not stated146Women initiating ARTNVP toxicity, hepatic toxicity, WHO grading of toxicity Ngoma et al. \[[@CR45]\]2008--2009279Women onlyHIV-free at 12 months, mortality rates, HIV transmission Torpey et al. \[[@CR46]\]2007--201028,320Children onlyHIV testing, type of PMTCT regimen Torpey et al. \[[@CR47]\]2007--20098237ChildrenHIV testing, type of PMTCT regimen Albrecht et al. \[[@CR48]\]2001--2003760Women onlyPMTCT drug adherence, partner disclosureSocial and behavioural change Kankasa et al. \[[@CR34]\]2004--200727,115Adults on ARTAdherence, mortality, loss to follow-up, CD4 count Goldman et al. \[[@CR49]\]2006--2007913Adults on ARTAdherence, viral load Carlucci et al. \[[@CR50]\]2006542Adults on ARTDrug adherence Birbeck et al. \[[@CR51]\]2005--2006255Adults on ARTDrug adherence*ART* antiretroviral therapy, *BMI* body mass index, *NVP* nevirapine

The majority of the papers were mostly large samples, with thousands of subjects, covering many different health facilities. The articles on HIV treatment and retention in care covered topics such as enrolment and retention into antiretroviral therapy, effectiveness of different drug regimens, coinfections with laboratory confirmed pathogens, comorbidities using clinical signs and symptoms, and food supplementation (Table [3](#Tab3){ref-type="table"}). The 15 PMTCT articles found addressed elimination of paediatric HIV infections, transmission of HIV to the babies, and improvement of survival in infected mothers and their exposed children.Table 3Studies utilising routinely collected data on HIV treatment and retention in care in ZambiaFirst authorData collection periodSample sizeSampled populationOutcomes assessedCantrell et al. \[[@CR52]\]2004--2005636Adults on ARTAdherence to medication, CD4, weight gainKoethe et al. \[[@CR53]\]2004--200827,915Adults initiating ARTWeight gain, death, treatment failure, BMITirivayi et al. \[[@CR54]\]2009291Adults on ARTAdherence to medication, CD4, BMIKoethe et al. \[[@CR55]\]2004--200956,612Adults on ARTCD4, mortality, BMIStringer et al. \[[@CR56]\]2004--200714,736Adults on ARTSingle dose substitution, CD4 count, haemoglobin level, BMI, mortalityChi et al. \[[@CR57]\]2007--201018,866Adults initiating ARTCD4, clinical disease staging, BMI, serum creatinine adherence, mortalityChi et al. \[[@CR58]\]2007--200910,485Adults on ARTDrug substitution, mortality, loss to follow-up, withdrawal and deathChi et al. \[[@CR59]\]2004--200824,366Adults on ARTCD4 counts, age clinical staging, haemoglobin, tuberculosis co-infection, adherenceChi et al. \[[@CR60]\]200733,704Adults on ARTCut-off points defining loss to follow-up, sensitivity, specificity, misclassification rateGiganti et al. \[[@CR61]\]2004--201040,410Adults on ARTHaemoglobin level, CD4, ART regimenVinikoor et al. \[[@CR62]\]201520,308Adults on ARTHBsAg, CD4, BMI, WHO stagingMulenga et al. \[[@CR63]\]2004--200725,779Adults on ARTMortality, creatinine clearanceStringer et al. \[[@CR64]\]2004--200521,755Adults initiating ARTClinical staging, CD4, mortality, BMI, haemoglobin level, adherenceSeu et al. \[[@CR65]\]2009--201268Adults failing treatmentCD4 count, adherence, HIV drug resistance mutationsKrebs et al. \[[@CR66]\]20051343Adults lost to follow-upCD4 count, BMI, mortality, home visit categories (traced, untraceable, died)Vinikoor et al. \[[@CR67]\]2004--201053,015Adults missing pharmacy refillsCD4 count, clinical staging, pharmacy refills, adherence, ART regimenVinikoor et al. \[[@CR68]\]2004--201192,130Adults on ARTAdherence, CD4 count, mortality, long-term follow-upHarris et al. \[[@CR69]\]2005--200720,153Tuberculosis/HIV co-infected adultsEnrolment on ART, CD4 count, WHO stagingMweemba et al. \[[@CR70]\]2011--201391,130Adults initiating ARTHepatitis B co-infection, WHO staging, CD4 countDeo et al. \[[@CR71]\]200713LaboratoriesCD4 count, haemoglobin, liver function testChi et al. \[[@CR72]\]2004--20066740Women exposed to nevirapineWHO stage, CD4 cell count, status, BMIBolton-Moore et al. \[[@CR73]\]2004--20074975Children on ARTCD4 percentage, weight-for-age Z scores, clinical staging, haemoglobin level, mortalityMubiana‐Mbewe et al. \[[@CR74]\]2004--20061705Children enrolled into careCD4 percentage, clinical staging, haemoglobin levelScott et al. \[[@CR75]\]2006--20111334Children on ARTCD4 percentage, fixed and variable unit costsKiage et al. \[[@CR76]\]2009--2011822Mother-infant pairsWHO staging, CD4/CD8 percentage, HIV, haemoglobin panel, maternal-CD4 countSutcliffe et al. \[[@CR77]\]2004--20081278Children on ARTEnrolment in ART, loss to follow-up, mortality, clinical staging, CD4 percentageIyer et al. \[[@CR78]\]2006--20111102Children initiating ARTAge, CD4 percentage, ART initiation, full blood count, blood chemistrySutcliffe et al. \[[@CR79]\]2004--2008863Children on ARTMortality, CD4, HIV, haemoglobin levelSutcliffe \[[@CR80]\]2000--2002492Children on ARTCD4 count, haemoglobin level, mortalityVan Dijk et al. \[[@CR81]\]2007--201277Children on ARTWeight-for-age Z scores, CD4 percentageVan Dijk et al. \[[@CR82]\]2007--2010198Children on ARTTreatment outcomes, viral load, CD4 percentage, retention in care, mortalitySutcliffe et al. \[[@CR83]\]2007--2009193Children initiating ARTWeight-for-age and height-for-age Z scoresNkamba \[[@CR84]\]Not stated59Children on ARTT cell subsets CD4 and CD8 memoryVan Dijk et al. \[[@CR85]\]2007--2008192Children on ARTYears of receiving ART, distance from clinic, CD4 percentage, weight-for-age Z scoreSinkala et al. \[[@CR86]\]2005--20065609Adults onlyColonoscopy, laparoscopy, culture resultsSheyo \[[@CR87]\]2009--2010452Adults and childrenHIV status, burn history, burn outcome and managementBrugha et al. \[[@CR88]\]2004--200739Health facilitiesVCT, ART, PMTCT, childhood immunisation service and coverage trendsKancheya et al. \[[@CR89]\]2003--2006203AdultsHIV status, VCTKaile et al. \[[@CR90]\]200418Adults on ARTBlood pressure serum potassium, creatinine and sodium, Karnofsky score, WHO staging*ART* antiretroviral therapy, *BMI* body mass index, *PMTCT* prevention of mother-to-child transmission, *VCT* voluntary counselling and testing

We found four articles on HTC covering couple counselling and provider-initiated testing and counselling. Articles on social and behaviour change looked at creating demand for adherence, prevention interventions, improved biomarkers and treatment uptake. Treatment and care had the largest number of articles with 39 articles covering the topic (Table [3](#Tab3){ref-type="table"}). Of the 62 articles, 33 full length papers utilised adult only routinely collected data and addressed retention in care, access to HIV treatment, mortality and clinical outcomes. A total of 16 full-length articles used data from only women, covering contraception, PMTCT and antenatal HIV prevalence rates. The articles using data on women only were published between 2010 and 2011, and had sample sizes ranging from 1435 to 138,884. There were 13 peer-reviewed articles that addressed paediatric HIV care and treatment. These were published between 2007 and 2013, with sample sizes ranging from 1120 to 4975. Our search did not reveal any articles utilising routinely collected HIV data specifically on adolescents aged 10--24 years old.

The 62 papers analysed were published in collaboration with partner institutions (Fig. [2](#Fig2){ref-type="fig"}). The Centre for Infectious Disease Research in Zambia and the University of Alabama had the highest contribution, with collaboration on 42 and 29 papers, respectively. The staff from national and district levels of the Ministry of Health participated in 40 of the published articles, while the lower collaboration was from institutions based in the United Kingdom, with collaboration on only 8 articles, four from LSHTM and four from other universities.Fig. 2Graph showing number of articles published by each collaborating institution

Discussion {#Sec6}
==========

The review of published articles showed that considerable strides are being made in utilisation of routinely collected HIV data in Zambia. A total of 62 articles were found and considered in this review. Treatment and retention in care and PMTCT had the highest contribution, with counselling and social and behavioural change having four articles each. However, we could not find published papers that utilised quantitative data analysis methods in our search on VMMC and condom programming despite the importance of these programmes and the inclusion of data from these programmes in SmartCare. The broad focus of the literature search on HIV in Zambia should have identified many papers on condom programming or VMMC, but the only papers found were qualitative studies on these topics. It was also observable during the search process that quantitatively analysed studies on HIV in adolescents in the country were limited and information for this age group has to be extracted from paediatric and adult studies.

This study was a collection of articles covering a diverse range of topics, which meant that no meta-analysis of the studies was possible. One of the goals of this paper was to highlight the range and diversity of the topics available for analysis using routinely collected data, and to explore the gaps in the published literature so far. The main topics were grouped into treatment and retention in care, PMTCT, HTC, condom programming and VMMC. Our search on VMMC and condom programming revealed no quantitatively analysed papers and few qualitatively analysed papers.

We did not include a large number of qualitatively analysed, clinical trial and survey-based articles, which have made important contributions to policy change in HIV care and treatment in Zambia. Further, risk of bias in individual study papers selected was not prioritised during the selection process since the rationale of the review was to assess the extent of utilisation of routinely collected data in the country. Only peer-reviewed articles where included because the assumption was that the peer-review process implies some form of quality control for biases in selected papers. In addition, only one of the authors reviewed the titles and abstracts, which could be a source of bias. However, as far as we are aware, this is the first study to provide such a baseline of studies for future referral.

The total number of published articles found in our literature search on the six HIV programmatic areas using routinely collected data meeting our criteria was quite low (an average of six articles per year) considering that these have been published in the past 10 years. This finding is lower than the 32 articles per year reported by Uthman \[[@CR17]\], but in line with findings by the Ministry of Health \[[@CR18]\], where the use and analysis of routinely collected data were found to be inadequate in Zambia, with analysed data displayed in graphs and information from the districts rarely used for decision-making at district levels. The reasons for these low numbers could be the limited data analysis skills, unavailability of data analysis software, disapproval or lack of support from supervisors, and lack of time and opportunity \[[@CR9]--[@CR11], [@CR18]--[@CR20]\]. It could be further argued that the limited use of routinely collected data was due to lack of knowledge on the benefits of analyzing such data at facility and district levels and poor data management, which could be alleviated by deliberate policy from government to support existing staff capacity building, operational research and publication of findings \[[@CR18], [@CR21]\].

Treatment and retention in care had the largest number of studies. This is in line with global trends in HIV prevention strategies where treatment and retention in care have been identified as the most effective HIV prevention tool among the biomedical prevention tools analysed to date \[[@CR22], [@CR23]\]; more research is encouraged in these areas. However, considering the period under review, the number of studies found on retention and care were rather low. Similar trends of low levels of publication in this area have been attributed to long follow-up periods required to monitor retention in care as well as to inconsistent information systems that make it difficult to track patients that seek care from multiple facilities \[[@CR24]\].

There was also a limited number of studies that looked at children born with HIV infection identified in our search. This is in line with findings from a systematic review of care and retention in HIV-infected children in low- and middle-income countries, where limited data were also found in Asia, Eastern Europe and Latin America \[[@CR25]\], attributed to emphasis on studies on adult data. It was also apparent that no quantitative peer-reviewed studies on treatment and retention among adolescents already in HIV care in Zambia were found in our search. Data on this age group has to be extracted from paediatric and adult studies. Similar findings have been reported in studies conducted in southern Africa in 2009 \[[@CR26]\] and 2010 \[[@CR27]\], where few data were reported on perinatally infected adolescents with most of the available data on adherence and outcomes emerging from the developed world. It is further argued that data for adolescents in southern Africa are disaggregated into 0--14, 15--19 and 15--24 year age groups, which makes it difficult to ascertain adolescent-specific data since, in most cases, the data includes very young children or adults \[[@CR28]\].

The search on condom programming revealed mostly intervention studies in settings where prospective users could access them. Reasons for this could be the mode of distribution, which is restricted to public health facilities and to private health facilities only on request \[[@CR29]\]. Similarly, Kane et al. \[[@CR30]\] argued that use of aggregate data on condom sales does not provide information on utilisation of condoms after they are obtained, resulting in the need for in-depth analysis on factors associated with condom use. The same could be concluded on usefulness of aggregate condom distribution data. Moreover, condom distribution data are difficult to document in routinely collected data and thus there is heavy reliance on survey data \[[@CR7]\]. There is an urgent need to understand the demographics of condom distribution in the country. Similar trends were revealed in the VMMC programme, which also yielded low numbers of peer-reviewed articles that utilised routinely collected quantitative data, despite the country not meeting its circumcision targets \[[@CR7]\].

Conclusion {#Sec7}
==========

There are positive advances being made in the HIV programme in the use of routinely collected data in Zambia. This progress must be nurtured and enhanced if Zambia is to reach elimination stages in HIV control. However, more efforts must be put into research and publishing results in critical areas, such as paediatric and adolescent care, VMMC and condom distribution, in order to build the skills and knowledge-base to deliver HIV services. Research on adolescent and childhood HIV morbidity and mortality outcomes as well as social behavioural change needs is important because HIV-infected adolescents and children are the key population in reducing HIV spread in their generation.

To improve the use of routinely collected data for use in publications the government could deliberately put in place policies to prioritise training of civil servants working in various programmes in operational research and consequently fund publishing of findings. These published articles would aid in international resource mobilisation for most programmes in the country as programme level data can be easily accessed in peer-reviewed articles.

HTC

:   HIV testing and counselling

PMS

:   patient monitoring system

PMTCT

:   prevention of mother to child transmission

VMMC

:   voluntary male circumcision
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